Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Jet Injection for Influenza: A Randomized Controlled Clinical Trial to Demonstrate Non Inferiority of Jet Injection vs. Needle and Syringe for Administration of Trivalent Inactivated Influenza Vaccine

NCT01688921 is registered in ClinicalTrials.gov with PharmaJet, Inc. as lead sponsor.

NCT NCT01688921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01688921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Jet Injection for Influenza: A Randomized Controlled Clinical Trial to Demonstrate Non Inferiority of Jet Injection vs. Needle and Syringe for Administration of Trivalent Inactivated Influenza Vaccine
Lead sponsor
PharmaJet, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
March 31, 2013
Enrollment
1,250 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human